Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

por Barzi, Afsaneh, Hess, Lisa M., Zhu, Yajun E., Liepa, Astra M., Sugihara, Tomoko, Beyrer, Julie, Chao, Joseph
Publicado 2019

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

por Shorr, Andrew F, Janes, Jonathan M, Artigas, Antonio, Tenhunen, Jyrki, Wyncoll, Duncan LA, Mercier, Emmanuelle, Francois, Bruno, Vincent, Jean-Louis, Vangerow, Burkhard, Heiselman, Darell, Leishman, Amy G, Zhu, Yajun E, Reinhart, Konrad
Publicado 2010